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Efficacy of Doll thErapy compared with standard treatment in the 
control of behavioral and psychologic Symptoms and CaRegIver 
Burden in dEmentia: DESCRIBE a randomized, controlled study
Behavioral and psychologic symptoms of dementia (BPSD) are 
frequent and represent a burden for patients and caregivers; in 
particular, the presence of agitation and aggression (A/A) has 
an important impact on patients’ quality of life. As psychotropic 
drugs can induce severe collateral effects, the use of a first line 
non-pharmacologic approach is highly recommended.
Here we evaluate the effect of doll therapy (DT) on A/A in geriat-
ric patients with moderate to severe dementia hospitalized in an 
acute geriatric unit.
We enrolled fifty-two acute in-patients with dementia and A/A. 
Subjects were randomized to DT (26) or standard treatment (ST, 
26), we measured agitation and caregiver burden with standard 
clinical scales at baseline and during treatment. In order to eval-
uate the effect of DT withdrawal, we carried out a telephonic fol-
low-up interview after 1 and 4 weeks from hospital discharge.
DT is more effective than ST in the control of agitation, but not 
in reducing the professional caregiver burden. The use of pro re 
nata psychotropic drugs was reduced in patients treated with DT. 
After DT withdrawal, A/A progressively increased. 
In conclusion we show that DT may be more effective than ST 
in the control of A/A in acute geriatric in-patients affected by de-
mentia. Our results suggest that, in patients affected by severe 
to moderate forms of dementia with A/A, DT may be used as a 
first line treatment, not only in nursing home residents, but also 
in acute care geriatric in-patients. 
Keywords: dementia; behavioral and psychologic symptoms in 
dementia; hospital; doll therapy; non-pharmacological approach.
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Introduction
In 2018 about 50 million people in the world lived
with dementia[1], as age is an important risk
factor for the development of dementia, the
number of patients affected by this disease is
expected to significantly rise within the next
years. According with the World Alzheimer
Report of 2018 the number of persons with
dementia will increase until 152 million in 2050[1].
The burden of dementia on health and social
care systems is enormous, the total estimated
worldwide cost due to the disease is about a
trillion US dollars/year, and this number is
forecasted to double by 2030[2]. Beyond the
financial impact, there is the emotional burden of
the disease: the unstoppable progression of the
patient toward the loss of communication
abilities, the loss of independency and the
development of behavioral and psychologic
symptoms of dementia (BPSD) represents a
huge emotional stress and an important burden
for the caregivers. BPSD includes agitation,
elation, wandering, depression, delusions and
hallucinations[3], affects more than 80% of
persons living with dementia[4–6] and often
presents in clusters[7]. BPSD will appear in about
20% of initially asymptomatic patients within two
years from the diagnosis, however almost the
100% of patients with dementia will present
BPSD at a certain point of their disease[8–10].
Amongst BPSD the presence of agitation and
aggression (A/A) severely affects patients’ and
caregivers’ quality of life[11,12], increases
disability with earlier institutionalization[13]
worsens with the disease progression [14] and is
associated with higher health care costs[15].
Although pharmacologic treatment is commonly
utilized for treating A/A, this approach is often
insufficient to control the symptoms[16]. Drugs
may cause severe adverse events as
extrapyramidal symptoms, somnolence,
sedation, fatigue, risk of falls, appetite and
weight gain, urinary incontinence, cardio-
vascular effects and cerebrovascular accidents
[17] may increase mortality [18] and may also
worsen cognitive performances [19]. Hence a
non-pharmacologic approach is considered as a
valid alternative to pharmacologic[20,21] and it is
strongly recommended as a first line treatment
for BPSD by the American Association for
Geriatric Psychiatry[22].
Non-pharmacologic approach include different
interventions: cognitive/ emotion-oriented inter-
ventions, that aim to improve emotional and
social function of patients with dementia, this
approach includes reminiscence therapy, valida-
tion therapy and orientation to reality[23]. Sensory
and multi-sensory stimulation interventions that
aim to increase alertness and reduce agitation
as art therapy, aromatherapy, music therapy,
and others[24]. Psychological interventions that
aim to ameliorate BPSD as behavior
management, animal-assisted therapy and
others, see for a systematic review[21]. Amongst
different non-pharmacologic approaches the doll
therapy (DT) has been extensively studied,
see[25] for a comprehensive review.
The mechanism of action of DT is not completely
understood, the attachment theory has been
evoked to explain the effect of DT in the
management of BPSD in patients living with
dementia[26,27]. Attachment theory was first
developed by John Bowlby mainly to explain the
behavior of abandoned children; however, it has
been further adapted to explain aging and
dementia[26,28,29] Attachment refers to the
emotional connection with a particular person;
the subject develops feelings of protection and
needs of care towards the loved one. Some of
the behaviors described as BPDS as wandering,
repetitive questioning, crying, agitation and even
aggressiveness in individuals with dementia
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might be interpreted as attachment requests. 
During BPSD, DT may catalyze patients’ 
attention and concentrate their requests and 
their emotions on the doll, that becomes a 
transitional object and, sometimes, is considered 
as a real baby needing care[30]. The attachment 
developed to the doll, brings the patient back to 
his/her past experiences as a person able to 
care for others instead of needing care[26,27,31]. 
Moreover, taking care of the doll may increase 
patients’ self-esteem[32], create therapeutic 
alliance bond[25], and help the patients to 
communicate with the environment and the 
caregivers [26,32,33]. Thus, DT may be a promising 
tool in the non-pharmacologic approach of 
BPSD in dementia.  
Until now DT has been mainly evaluated in 
nursing homes, reviewed in[25,31], overall the 
studies reported an amelioration of BPSD, with 
improvement of wellbeing, reduction of the use 
of antipsychotic drugs[34]and increase in the 
therapeutic alliance between the patients and 
the professional caregivers[25,35]. However the 
majority of the studies on DT were cohort, case-
control and observational studies[25]. The 
efficacy of DT was assessed only in long-term 
care facilities and not in acute geriatric in-
patients, thus we designed this study in order to 
evaluate the efficacy of DT in patients with 
dementia and A/A in an acute geriatric unit with 
a randomized controlled approach.  
Methods 
Study design 
DESCRIBE is a randomized controlled trial with 
two parallel arms, developed in order to assess 
the efficacy of DT compared with Standard 
Treatment (ST) in the control of A/A and in 
relieving the caregiver burden in persons with 
dementia hospitalized in an acute geriatric unit. 
The study follows the Consolidated Standards of 
Reporting Trials (CONSORT) guidelines for non-
pharmacologic treatments[36].  
Participants  
To evaluate the role of DT in acute patients we 
enrolled acute geriatric in-patients hospitalized 
in the Geriatric and Bone Diseases Unit of the 
City of Health and Science Hospital in Torino 
(TO) between the 1 January 2019 and 31 
October 2019 according with the following 
inclusion/exclusion criteria.  
Inclusion criteria: age ≥65 years; diagnosis of 
dementia moderate to severe Clinical Dementia 
Rating scale (CDR) ≥2; presence of agitation 
and/or aggressiveness; manual and visual 
abilities sufficient in order to interact with the doll. 
Exclusion criteria: age <65 years; refuse to 
participate; mild forms of dementia (CDR<2); 
contrainication for DT as experience of mournful 
or traumatic events related to parental 
experience; life expectancy lower than 3 months; 
infectious diseases requiring isolation; negative 
interaction with the doll.  
Patients were randomly assigned at doll therapy 
(DT) or standard treatment (ST), the 
randomization was carried out by computer-
generated tables to allocate treatments: the 
patients received a consecutive number after 
enrolment and were subsequently allocated to 
randomization list, according with[37]. The PI 
generated the randomization list.  
Intervention 
The doll used in the study is the “empathy doll”; 
these dolls are designed to obtain an optimal 
interaction with patients and to arouse empathy 
(Fig. 1).  
Nurses responsible for doll administration 
received detailed information on the aim of the 
study and on the role of DT in controlling A/A. An 
expert neuropsychologist was responsible to 
train nursing staff in the doll administration and 
in the observation of patients’ interaction with the 
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doll. The researchers informed patients’ 
caregivers on the aim and the efficacy of DT by 
a one-to-one discussion, at the end of the 
discussion an informative brochure was 
released. In order to evaluate the patients 
interaction with the doll we used the 
Engagement Observation Rating Tool for Doll 
Therapy [35,38]. Patients with positive attitude 
(good attention and attitude and appropriate 
interaction with doll) and neutral attitude (ignore 
the doll) towards the doll were included in the 
study and immediately randomized to DT or 
standard treatment (ST). Patients with negative 
interaction (refuse the doll, become agitated and 
or aggressive) were excluded from the study.  
 
 
Figure 1. Empathy dolls. The pictures show the dolls used in the study (panel A), interaction 
between patient and doll (panel B). 
 
The trained nurse introduced the doll to the 
patient as gift: “good morning Mr/Mrs look! This 
is for you!”, and left the doll in his/her room such 
as it can be easily accessible; the researcher 
observe the patient interaction with doll for 5 
minutes after administration and 5 minutes 
before the end of administration. Interaction 
between patients and doll was noted in the 
Observation Rating Tool for Doll Therapy. 
Nurses interacted with patient and doll at 
administration and withdrawal; otherwise, the 
patient was allowed to freely interact with the doll. 
If the patient refuse the doll, the caregiver would 
not insist.  
In DT group the doll were administered two times 
a day for two hours in the morning, two hours in 
the afternoon and in case of agitation/ 
aggressiveness. The administration of DT was 
the treatment first choice; if the agitation/ 
aggressiveness persist, the use of pharmaco-
logic treatment was allowed and noted. In the 
control group, the caring physician was allowed 
to choose the psychotropic drugs, according with 
standard clinical care (ST). For the pro re nata 
(PRN) psychoropic drug administration in case 
of A/A, haloperidol was used as first line 
treatment, promazin as second line. DT and 
controls were comparable for used for the 
control of BPSD at baseline (Table 1).  
In order to evaluate the effect of discontinuation 
of DT, we carried out a follow-up by telephonic 
interviews after 1 and 4 weeks from hospital 
discharge; whilst DT was stopped, antipsychotic 
drugs treatment was continued. Figure 2 shows 
the study flow chart.
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Table 1. Treatment used for the control of BPSD at baseline according to randomization. Percentage 




Figure 2. Study flow chart. The diagram shows the study design with the number of patients at each 
visit. 
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Outcomes  
Primary outcomes were the effect of DT on A/A 
and on professional caregiver burden  
Secondary outcome was the effect of DT on 
family caregiver burden.  
Analyzed variables  
Presence of A/A was evaluated with the A.Di.Co 
scale, this is a scale derived from the DISCO 
scale[14,40].The A.Di.Co evaluate the presence of 
BPSD using 10 items dived in clusters.  
The scores is zero if there are no BSPD, 1 if 
there is the patient is anxious or verbally 
aggressive or has hallucination (mild agitation), 
2 correspond to the presence of moderate to 
severe agitation (A/A), the patient is agitated, 
physically aggressive or defensive.  
In order to evaluate the professional caregiver 
burden we used the Gruetzner scale[41];the 
family caregiver burden was evaluated by the 
Caregiver Burden Inventory (CBI) scale[42],the 
presence of delirium was evaluated by the use 
of the Assessment test for delirium and cognitive 
impairment (4AT)[43]. Cognition and functional 
status were evaluated by the Short Portable 
Mental Questionnaire (SPMQ)[44],he Activity of 
Daily Living (ADL) scale and the Instrumental 
Activity of Daily Living (IADL) score[45] 
respectively.  
Age, gender, length of hospital stays, and type 
of hospital discharge were also recorded. Data 
collection and analyses were blinded as respect 
to patients’ treatment.  
Variables of interest were collected at baseline, 
at hospital discharge and after 1 and 4 weeks 
from hospital discharge by telephonic interviews 
(Fig. 2).  
Statistical analyses  
As no previous studies measured the efficacy of 
DT in different setting using A.Di.CO the power 
analysis was conducted using an estimated 
large effect size (f = 0.40), an alpha level of 0.05, 
and a power of 0.8. A sample size of 52 is 
necessary (26 each group) for primary 
outcomes[46].  
All the analyzed variables were tested for 
normality by the kurtosis test and they were all 
normally distributed. Patients randomized to DT 
were compared to patients randomized to ST by 
one-way ANOVA for continuous variables and 
by χ2 test for gender. The effect of DT was 
evaluated per protocol using the two-way 
ANOVA for repeated measurements.  
The PRN antipsychotic drugs administration was 
normalized for the length of hospital stay 
(number of PRN administration/length of hospital 
stay) and compared amongst the two groups by 
means of the Student’s T-test for unpaired 
values. SPSS 25.0 were used for the statistical 
analyses and p<0.05 was considered 
statistically significant. Graphs were drawn using 
GraphPad 8.0 for Windows.  
Ethical considerations 
The Ethical Committee “Comitato Etico 
Interaziendale AO Città della Salute e della 
Scienza di Torino” approved the study (Ref. no. 
CE il 04/10/2018 protocol number 0098548).  
Results 
Fifty-four patients were eligible to the study, of 
those, 52 were enrolled, as two refused to 
participate. All the enrolled patients had a 
positive interaction with the doll (Fig.2).  
DT is effective in reducing agitation and 
aggressiveness in acute geriatric in-patients.  
The DT group did not significantly differ from 
patients in ST group for age, gender, cognition, 
level of independence, presence of delirium, 
duration of in hospital stay presence of A/A, 
professional and family caregiver burden (Table 
2). The mean length of hospital stay was 10±1 
days without statistical differences between the 
two treatment groups. During hospitalization 
three patient died, one in the ST and two in the 
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DT group. At discharge, DT was withdrawn in all 
the patients, except for one patient who wished 
to continue the treatment and has been 
considered lost at follow-up. After the first week, 
six patients were lost at follow up as it was 
impossible to reach them by phone, at the end of 
follow-up four patients were dead (Fig.2).  
 
Table 2. General characteristics of patients according with treatment. Mean ± SE are shown, p 
values were calculated by one-way ANOVA and by χ2 test for gender. CBI: Caregiver Burden Inventory  
4AT: Assessment test for delirium and cognitive impairment ADL: Activity of Daily Living IADL: Instrumental Activity of 
Daily Living SPMQ: Short Portable Mental Questionnaire CDR: Clinical Dementia Rating scale 
 
Figure 3. Effect of doll therapy in acute geriatric patients. Effect of DT versus ST on the ontrol of 
BPSD measures as A.Di.CO (panel A). Effect of DT versus ST in relieving the professional caregiver 
measured by the Gruetzner scale (panel B) and the family caregiver urden (C.B.I, panel C). Effect 
of DT versus ST in reducing the risk of delirium measured by 4AT (panel C). Effect of DT versus ST 
on the administration of PRN (panel D). Results of two-way ANOVA for repeated measurements are 
shown in box, significant differences versus aseline are shown by *. P values for PRN were 
compared by Student’s T test.  
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DT was more effective in reducing A/A during 
hospital stay as respect to ST (Fig.3A), DT and 
ST were both ineffective in relieving the 
perceived professional caregiver burden (Fig. 3B) 
and in reducing the incidence of delirium (Fig. 
3C). As regards pharmacologic treatment, the 
use of PRN was significantly lower in the DT 
group (Fig. 3D). In details, PRN administration 
was necessary in ≤2 times in 3 patients (11.5%) 
and more than 2 times during hospitalization in 2 
patients (7.7%) in DT group; whereas in the ST 
group 13 patients (50%) needs PRN, of those 7 
(27%) received more than 2 doses.  
 
 
Figure 4. Effect of interruption of doll therapy in patients discharged from hospital. Effect of 
interruption of DT versus ST on the control of BPSD measures as A.Di.CO (panel A). Effect f 
interruption of DT versus ST on the professional caregiver measured by the Gruetzner scale (panel 
B) and the family caregiver burden (C.B.I, panel C). Effect of interruption of DT versus ST in reducing 
the risk of delirium measured by 4AT (panel D). Results of two-way NOVA for repeated 
measurements are shown in box, significant differences versus baseline are shown by *. 
 
In order to evaluate the effect of DT withdrawal, 
all the patients were followed up for one month 
after hospital discharge with two telephonic 
interviews after 1 and 4 weeks.  
During follow up we observed an increase in A/A, 
that was significantly higher in patients 
previously treated with DT (Fig.4A), there were 
no significant change in the professional (Fig.4B) 
and familiar (Fig.4C) caregiver burden. The 
Greutzner scale was evaluated at follow-up in 
patients discharged in nursing homes or long-
term care units (22), whereas in patients 
returning home (20) only the C.B.I was 
evaluated. We observed a significant decrease 
in the incidence of the delirium regardless to 
previous treatment (Fig. 4D).  
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Discussion 
Non-pharmacologic approach is highly 
recommended for patients with dementia and 
BPSD[22];amongst non-pharmacologic treatment 
the use of doll therapy has been shown as 
effective in the control of agitation and 
aggressiveness in patients affected by severe 
forms of dementia (reviewed in [25]). Despite 
general positive findings due to the type of 
intervention, a standardized approach is difficult 
to reach, there have been some attempt towards 
standardization of DT with well-designed 
randomized controlled clinical trials[47–50],the 
results of these trials agree on the efficacy of DT 
in ameliorating BPSD in nursing home residents. 
As regards acute hospital setting, this is the first 
attempt to evaluate the efficacy of DT with a 
randomized controlled approach.  
This topic is of particular relevance as persons 
living with dementia are frequently 
hospitalized[51,52] and hospitalization heavily 
contributes to the increase of frequency and 
magnitude of BPSD[53,54] causing distress for 
both families[55] and professional caregivers[54]. 
Pharmacologic treatments used to control A/A 
are often burdened by severe collateral effects 
that may prolong hospital stay and increase the 
risk of in-hospital mortality[56], whereas non-
pharmacologic approaches have less collateral 
effects[20,21].  
DESCRIBE shows that, despite the short period 
of intervention, DT is effective in reducing A/A 
and in reducing the administration of PRN 
psychotropic drugs in an acute hospital setting. 
Reduction of psychotropic PRN may reduce 
collateral effects due to psychotropic 
administration and ameliorate clinical outcomes 
[16]. After DT withdrawal, we observed a 
progressive increase in A/A, despite hospital 
discharge. Even if these data may further 
support the role of DT in reducing agitation and 
aggressiveness, a certain caution in their 
interpretation is due as, we do not have data on 
potentially confounding factors as changes in the 
patients’ psychosocial needs and in social 
interaction after hospital stay.  
Despite the reduction of A/A we did not find a 
reduction in the professional caregiver burden, 
this may be due to the different components of 
the burden detected by the Gruetzner scale. In f- 
act, patients’ agitation and aggressiveness is dir- 
ectly evaluated in only one item of the scale.  
There are still some barriers in the application of 
DT, in fact some concerns about its extensive 
use have been raised: caregivers may be 
concerned by feelings of “infantilizing” the 
patient[57] and disputes between owners and 
non-owners of a doll have been reported. 
Furthermore, in some patients’ dolls may lead to 
discomfort and distress [32], hence before starting 
DT it is important to evaluate the patient’s 
attitude toward the doll. In our study, none of the 
caregivers, after adequate information, raised 
concerns about the use of dolls as first-line 
treatment in controlling patient’s agitation/ 
aggressiveness, furthermore we did not 
observed disputes between owners and non-
owners of a dolls even though the interaction 
between patients was not standardized and 
noted. A qualitative revision of clinical dossiers 
shows no disputes because of the doll. We do 
not observe negative interaction with the doll; it 
was generally well accepted and perceived as a 
gift.  
As major limitation of our study, we 
acknowledged the lack of homogeneity in 
psychotropic drugs used; however, due to 
different clinical manifestation of patients with 
dementia it is almost impossible to standardize 
the treatment. Nevertheless, patients 
randomized to DT and ST were treated with 
similar drugs, thus reducing the bias. Moreover, 
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comparing DT with common clinical practice 
allow us to generalize our findings.  
Before introduction of DT it is important to 
evaluate the patients’ interaction with the doll, to 
have specific trained personnel and to discuss 
the treatment with the patient and the family. 
Patients with negative attitude towards the doll 
must not be treated with DT in order to avoid 
possible secondary effects as increased 
agitation and aggressiveness. The need for 
specific trained personnel may reduce the 
utilization of DT in acute hospital units; therefore, 
specific studies to clarify the cost effectiveness 
of this intervention may be useful to support the 
use of DT in the everyday clinical practice.  
In conclusion, DT may be an option for the 
treatment of A/A also in acute care hospital units 
in patients with moderate to severe dementia as 
first line treatment.  
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